Tuberculosis can remain latent for decades, and billions of people worldwide are infected, yet this is the stage of the disease about which the least is known. There has been an explosion of research data about the state of dormancy of the mycobacterial pathogen and the adaption of the pathogen to residence in the host, both at the level of gene expression and protein expression. At the same time very little is known about host immune reactions during the period of latency, especially those reactions which are localized in the granulomatous inflammatory lesions. The hard walled granuloma acts to prevent the dissemination of the pathogen and also protects the surrounding host tissue. The extent to which it also shields the bacteria from sterilizing immunity and possibly prevents access of the immune system to the pathogen is unknown. There is an urgent need for information about the specific immune response against dormant mycobacteria. In particular, little to no information is available about the extent to which host dendritic cells (DC) are able to sample antigens exclusively expressed by dormant, granuloma dwelling bacteria. Similarly, the systemic response of T cells to latency antigens has not been widely characterized. We will induce granulomas in murine liver using a Mycobacterium bovis strain bacille Calmette Guirin (BCG) infection model. Liver pieces containing granulomas will be transplanted into mice at the chronic stage. By taking advantage of fluorescence-tagged DC, T cells and bacteria localized in chronic granulomas, we will trace their traffic from the transplant. By using combinations of genetically epitope-tagged BCG and T cell receptor transgenic mice we will also test the capacity of donor-derived DC to present latent mycobacterial antigens and the systemic response of T cells to latent mycobacterial antigens. PUBLIC HEALTH RELEVENCE:Our experiments will ask the key question of whether during chronic mycobacterial infection, the granuloma sequestered bacteria are able to induce a systemic host immune response or not. The potential answers from these experiments could be critically important to the tuberculosis vaccine effort. These experiments will increase our understanding of other infectious and autoimmune granulomatous diseases and their long- term immunopathologies. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21AI072638-01A2
Application #
7471830
Study Section
Immunity and Host Defense Study Section (IHD)
Program Officer
Lacourciere, Karen A
Project Start
2008-03-01
Project End
2010-02-28
Budget Start
2008-03-01
Budget End
2009-02-28
Support Year
1
Fiscal Year
2008
Total Cost
$181,745
Indirect Cost
Name
University of Wisconsin Madison
Department
Pathology
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Schreiber, H A; Harding, J S; Altamirano, C J et al. (2011) CONTINUOUS REPOPULATION OF LYMPHOCYTE SUBSETS IN TRANSPLANTED MYCOBACTERIAL GRANULOMAS. Eur J Microbiol Immunol (Bp) 1:59-69
Okunade, A L; Clark, A M; Hufford, C D et al. (1999) Azaanthraquinone: an antimicrobial alkaloid from Mitracarpus scaber. Planta Med 65:447-8
Donkor, I O; Klein, C L; Liang, L et al. (1995) Synthesis and antimicrobial activity of 6,7-annulated pyrido[2,3-d]pyrimidines. J Pharm Sci 84:661-4
Li, E; Clark, A M; Rotella, D P et al. (1995) Microbial metabolites of ophiobolin A and antimicrobial evaluation of ophiobolins. J Nat Prod 58:74-81
Li, E; Clark, A M; Hufford, C D (1995) Antifungal evaluation of pseudolaric acid B, a major constituent of Pseudolarix kaempferi. J Nat Prod 58:57-67
Okunade, A L; Hufford, C D; Richardson, M D et al. (1994) Antimicrobial properties of alkaloids from Xanthorhiza simplicissima. J Pharm Sci 83:404-6
Hammerschmidt, F J; Clark, A M; Soliman, F M et al. (1993) Chemical composition and antimicrobial activity of essential oils of Jasonia candicans and J. montana. Planta Med 59:68-70
Jurgens, T M; Hufford, C D; Clark, A M (1992) The metabolism of muzigadial by microorganisms. Xenobiotica 22:569-77
Peterson, J R; Zjawiony, J K; Liu, S et al. (1992) Copyrine alkaloids: synthesis, spectroscopic characterization, and antimycotic/antimycobacterial activity of A- and B-ring-functionalized sampangines. J Med Chem 35:4069-77
Liu, S C; Oguntimein, B; Hufford, C D et al. (1990) 3-Methoxysampangine, a novel antifungal copyrine alkaloid from Cleistopholis patens. Antimicrob Agents Chemother 34:529-33